Loading clinical trials...
Loading clinical trials...
Effect of NeuroAD, Combined TMS Stimulation and Cognitive Training, on the Cognitive Function of Mild to Moderate Alzheimer Patients
The study tests the effect of the NeuroAD on Alzheimer patients' cognitive function. The NeuroAD uses non-invasive stimulation of both magnetic and cognitive training.
The NeuroAD system is a combined system of Transcranial Magnetic Stimulation and cognitive training and is a non-invasive therapeutic system for the improvement of Alzheimer patients' cognitive function. A potential participant will undergo screening procedures to confirm eligibility to participate in the study, followed by randomization procedure to one of the study groups - treatment or sham (placebo) Patient will attend the clinic 5 times a week for 6 weeks, approximately an hour every day for treatment/sham. The patient will be required to return to the clinic for follow-up. Up to 150 patients will be enrolled in up to 10 clinical sites in the US and Israel.
Age
60 - 90 years
Sex
ALL
Healthy Volunteers
No
Banner Sun Health Research Institute
Sun City, Arizona, United States
ATP Clinical Research, Inc.
Costa Mesa, California, United States
Miami Jewish Health Systems
Miami, Florida, United States
Roskamp Institute Clinic
Sarasota, Florida, United States
Palm Beach Neurology and Premiere Research Institute
West Palm Beach, Florida, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Cleveland Clinic Lou Ruvo Brain Center
Las Vegas, Nevada, United States
NYU Langone Medical Center
New York, New York, United States
Cleveland Clinic Center for Brain Health Lakewood Hospital
Cleveland, Ohio, United States
Assaf Harofe Medical Center
Beer Yaakov, Israel
Start Date
October 1, 2013
Primary Completion Date
January 1, 2016
Completion Date
March 1, 2016
Last Updated
March 31, 2016
131
ACTUAL participants
TMS and cognitive stimulation
DEVICE
sham
DEVICE
Lead Sponsor
Neuronix Ltd
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07033494